Using cost-effectiveness analysis to address health equity concerns

Cookson, Richard, Mirelman, Andrew J., Griffin, Susan, Asaria, Miqdad ORCID: 0000-0002-3538-4417, Dawkins, Bryony, Norheim, Ole Frithjof, Verguet, Stéphane and J. Culyer, Anthony (2017) Using cost-effectiveness analysis to address health equity concerns. Value in Health, 20 (2). pp. 206-212. ISSN 1098-3015

Text (Using cost-effectiveness analysis to address health equity concerns) - Published Version Available under License Creative Commons Attribution. Download (445kB)

• Author

Abstract

This articles serves as a guide to using cost-effectiveness analysis (CEA) to address health equity concerns. We first introduce the “equity impact plane,” a tool for considering trade-offs between improving total health—the objective underpinning conventional CEA—and equity objectives, such as reducing social inequality in health or prioritizing the severely ill. Improving total health may clash with reducing social inequality in health, for example, when effective delivery of services to disadvantaged communities requires additional costs. Who gains and who loses from a cost-increasing health program depends on differences among people in terms of health risks, uptake, quality, adherence, capacity to benefit, and—crucially—who bears the opportunity costs of diverting scarce resources from other uses. We describe two main ways of using CEA to address health equity concerns: 1) equity impact analysis, which quantifies the distribution of costs and effects by equity-relevant variables, such as socioeconomic status, location, ethnicity, sex, and severity of illness; and 2) equity trade-off analysis, which quantifies trade-offs between improving total health and other equity objectives. One way to analyze equity trade-offs is to count the cost of fairer but less cost-effective options in terms of health forgone. Another method is to explore how much concern for equity is required to choose fairer but less cost-effective options using equity weights or parameters. We hope this article will help the health technology assessment community navigate the practical options now available for conducting equity-informative CEA that gives policymakers a better understanding of equity impacts and trade-offs.

Item Type:	Article
Additional Information:	© 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Divisions:	LSE Health
Subjects:	R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine H Social Sciences > HD Industries. Land use. Labor > HD28 Management. Industrial Management
Date Deposited:	26 Jul 2019 11:12
Last Modified:	15 Nov 2024 08:24
URI:	http://eprints.lse.ac.uk/id/eprint/101230

Actions (login required)

View Item